Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
191,379
-
Share change
-
+191,379
-
Total reported value
-
$1,685,545
-
Price per share
-
$8.53
-
Number of holders
-
14
-
Value change
-
+$1,685,545
-
Number of buys
-
14
Institutional Holders of Finch Therapeutics Group, Inc. - COM NEW (FNCH) as of Q2 2023
As of 30 Jun 2023,
Finch Therapeutics Group, Inc. - COM NEW (FNCH) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
191,379 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, LAKE STREET ADVISORS GROUP, LLC, Ikarian Capital, LLC, Bleichroeder LP, Tower Research Capital LLC (TRC), UBS Group AG, Ancora Advisors, LLC, and BlackRock Inc..
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.